Skip to content

13F-HR filed by SPHERA FUNDS MANAGEMENT LTD.

SPHERA FUNDS MANAGEMENT LTD. filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-14, with 79 holding rows worth $647,319,000.

Accession
0001178913-19-002713
Filed
2019-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 80 entries on the cover page, a total value of $647,319,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $647,318,000 with VALUE read as thousands by filing date, 13F file number 028-15863. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Bristol-Myers Squibb Company110122108COM1,109,900$56,283,000thousands by filing date
Johnson & Johnson478160104COM400,000$51,752,000thousands by filing date
Gilead Sciences,Inc.375558103COM705,000$44,683,000thousands by filing date
Merck & Co.,Inc.58933Y105COM470,000$39,565,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR700,000$32,431,000thousands by filing date
CELGENE CORP151020104COM250,000$24,825,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM2,930,320$23,501,000thousands by filing date
NOVO-NORDISK A S ADR670100205ADR450,000$23,265,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM248,038$18,682,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM165,713$16,230,000thousands by filing date
ARQULE INC04269E107COM2,082,643$14,933,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR1,550,000$10,664,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM310,000$10,484,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS74,000$8,512,000thousands by filing date
MELLANOX TECHNOLOGIES LTDM51363113COMMON STOCK76,875$8,425,000thousands by filing date
NICE LTD SPONSORED ADR653656108ADR57,193$8,224,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM565,000$8,113,000thousands by filing date
UROGEN PHARMA LTDM96088105COMMON STOCK335,817$8,003,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM660,000$7,689,000thousands by filing date
CAESARSTONE LTDM20598104ORD SHS461,509$7,666,000thousands by filing date
Microsoft Corp594918104COM53,741$7,472,000thousands by filing date
STOKE THERAPEUTICS INC86150R107COM346,380$7,384,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR73,773$7,106,000thousands by filing date
UNIQURE NVN90064101SHS177,500$6,986,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock260,000$6,973,000thousands by filing date
FISERV INC337738108COM67,279$6,969,000thousands by filing date
PALO ALTO NETWORKS INC697435105COM32,976$6,721,000thousands by filing date
SPRINGWORKS THERAPEUTICS INC85205L107COM310,000$6,721,000thousands by filing date
EXICURE INC30205M101COM2,637,988$6,674,000thousands by filing date
FORESCOUT TECHNOLOGIES INC34553D101COM173,696$6,587,000thousands by filing date
AUDIOCODES LTDM15342104ORD328,263$6,207,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock762,018$5,906,000thousands by filing date
NEOS THERAPEUTICS INC64052L106COM3,908,265$5,784,000thousands by filing date
VERINT SYS INC92343X100COM134,489$5,753,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM1,069,089$5,634,000thousands by filing date
SOLAREDGE TECHNOLOGIES INC83417M104COM64,002$5,358,000thousands by filing date
ALLOT LTDM0854Q105SHS661,031$5,328,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO915,000$5,270,000thousands by filing date
HARPOON THERAPEUTICS INC41358P106COM374,031$5,109,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A63,269$5,080,000thousands by filing date
Y-mAbs Therapeutics Inc984241109Common Stock190,000$4,951,000thousands by filing date
CHIASMA INC16706W102COM990,000$4,901,000thousands by filing date
ARVINAS INC04335A105COM205,281$4,424,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR38,581$4,397,000thousands by filing date
AXOVANT SCIENCES LTDG0750W203COM668,541$4,319,000thousands by filing date
WIX COM LTD SHSM98068105Stock36,890$4,307,000thousands by filing date
ZYMEWORKS INC98985W102COM170,000$4,216,000thousands by filing date
KRYSTAL BIOTECH INC COM501147102Stock117,625$4,085,000thousands by filing date
KORNIT DIGITAL LTDM6372Q113SHS131,588$4,050,000thousands by filing date
BURLINGTON STORES INC COM122017106Stock19,500$3,896,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM422,589$3,841,000thousands by filing date
RETROPHIN INC761299106COM330,203$3,827,000thousands by filing date
Amazon.com, Inc023135106COM2,200$3,819,000thousands by filing date
ITURAN LOCATION AND CONTROL SHSM6158M104Stock135,311$3,354,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM90,000$3,239,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM42,500$3,122,000thousands by filing date
PRECISION BIOSCIENCES INC74019P108COM365,000$3,062,000thousands by filing date
AKERO THERAPEUTICS INC00973Y108COM130,000$2,958,000thousands by filing date
WABTEC COM929740108Stock40,000$2,874,000thousands by filing date
Allena Pharmaceuticals, Inc.018119107COM673,881$2,655,000thousands by filing date
FIVERR INTL LTD ORD SHSM4R82T106Stock141,355$2,643,000thousands by filing date
CHARTER COMMUNICATIONS INC N16119P108COM6,000$2,473,000thousands by filing date
ARYA SCIENCES ACQUISITION COG3165V117UNIT 10/04/2023200,000$2,188,000thousands by filing date
DELEK US HLDGS INC NEW COM24665A103Stock50,000$1,815,000thousands by filing date
TECTONIC THERAPEUTIC INC COM05455M100Stock126,324$1,784,000thousands by filing date
NOVA LTD COMM7516K103Stock51,949$1,650,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328700COM2,141,800$1,542,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM120,000$1,180,000thousands by filing date
PREVAIL THERAPEUTICS INC74140Y101COM90,217$1,108,000thousands by filing date
HEALTH SCIENCES ACQUSTN CORP42227C201UNIT 04/01/2024100,000$1,073,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM140,000$823,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM750,000$788,000thousands by filing date
Arbutus Biopharma Corp03879J100Common Shares, without par value500,000$763,000thousands by filing date
X4 Pharmaceuticals, Inc.98420X103COM47,391$602,000thousands by filing date
PHAXIAM THERAPEUTICS S A29604W108SPONSORED ADR117,837$523,000thousands by filing date
CUE BIOPHARMA INC22978P106COM50,000$422,000thousands by filing date
Mersana Therapeutics Inc59045L106Common Stock200,000$316,000thousands by filing date
TUFIN SOFTWARE TECHNOLOGIS LM8893U102SHS12,231$201,000thousands by filing date
CELLECTAR BIOSCIENCES INC15117F500COM PAR87,500$175,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001178913-19-002713this filing2019-11-14acceptance time not in the bulk data set